A Comprehensive HBsAg-positive Patients Centered Screening Strategy

CompletedOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

February 20, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Hepatitis B and Hepatitis C (Disorder)
Interventions
BEHAVIORAL

education

Education Methods including video playing of HCV Introduction (disease profile, risk factors for infection, outcomes, HBV/HCV coinfection, reinfection, etc) for 5 min, booklets of relative information distribution, physicians and nurses consulting in clinic.

BEHAVIORAL

no education

Education Methods including video playing of HCV Introduction (disease profile, risk factors for infection, outcomes, HBV/HCV coinfection, reinfection, etc) for 5 min, booklets of relative information distribution, physicians and nurses consulting in clinic.

Trial Locations (1)

400010

The 2nd affiliated Hospital of Chongqing Medical University, Chongqing

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Hong Ren

OTHER

NCT03794791 - A Comprehensive HBsAg-positive Patients Centered Screening Strategy | Biotech Hunter | Biotech Hunter